Model Informed Drug Development Archives | Page 4 of 42 | Certara

Poster

Integrated Population Pharmacokinetic Model of Bemnifosbuvir and Metabolites

CertaraNovember 22, 2024

Poster

Indirect Exposure-Response Modeling for Transthyretin Amyloid Cardiomyopathy Treated with Acoramidis (AG10)

CertaraNovember 22, 2024

Poster

Model-Informed Drug Development Framework for the Development and Dose Optimization of Targeted Radiation Therapies

CertaraNovember 22, 2024

Poster

Augmented Definitive Screening Design Provides Efficient Phase 1 Selection of CAR T-cell and Lymphodepletion Regimen

CertaraNovember 22, 2024

Poster

Oncology MIDD Simulator, A User-Friendly Application for Overall Survival Forecasting in Early Oncology Trials

CertaraNovember 22, 2024

Poster

Quantitative Systems Pharmacology model for combined targeting of BAFF and CD40 pathways in systemic lupus erythematosus

CertaraNovember 22, 2024

Poster

Population pharmacokinetic modeling of niraparib to assess different absorption models

CertaraNovember 22, 2024

Publication

Recent applications of pharmacometrics and systems pharmacology approaches to improve and optimize drug therapy for pregnant and lactating women

The article "Recent Applications of Pharmacometrics and Systems Pharmacology Approaches to Improve and Optimize Drug…

CertaraNovember 18, 2024

Blog

PBPK Modeling to Support Bioequivalence & Generic Product Approvals

Physiologically-based pharmacokinetic modeling can be used to support bioequivalence (BE) assessment of complex and locally…

CertaraNovember 12, 2024

Publication

A Sequential Population Pharmacokinetic Model of Zilovertamab Vedotin in Patients with Hematologic Malignancies Extrapolated to the Pediatric Population

CertaraNovember 7, 2024

© 2025 Certara. All Rights Reserved. | Privacy policy